NEW YORK (TheStreet) -- RATINGS CHANGES
Gilead (GILD) - Get Report was upgraded at Morgan Stanley to overweight from equal-weight. Twelve-month price target is $104. Fear over Abbvie (ABBV) - Get Report pricing has created a buying opportunity, Morgan Stanley said.
Halyard Health (HYH) was initiated with an outperform rating at JMP Securities. Twelve-month price target is $50. Company should benefit from lower raw materials costs and can make a small acquisition to augment growth, JMP Securities said.
Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes," which is available only to Real Money subscribers. To find out how to become a subscriber, please click here.
This article was written by a staff member of TheStreet.